Cancer biotech ImmVirX taps Bell Potter for $20m pre-IPO
SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by global pharma… read more
12 new senior healthcare executives sought for key roles
MELBOURNE: Twelve senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
CSL gives up on plans to develop COVID treatment
SYDNEY: CSL has shelved plans to develop a coronavirus treatment using the plasma of recovered… read more
Retirees are super spenders claims new research report
MELBOURNE: Senior Australians are dying without a cent of superannuation, according to new research that… read more
